BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN
BEGIN:VTIMEZONE
TZID:Central Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Central Standard Time
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Central Daylight Time
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Please join the PFF and industry representatives for the PFF CT
 I Webinar Series. You will learn about various research studies underway t
 o help find new treatments for pulmonary fibrosis and interstitial lung di
 sease.CTI Webinar Series February PresentersMIST StudyTrial Sponsor: Avaly
 n PharmaSpeaker: Craig Conoscenti\, MD\, Senior Vice President of Clinical
  Development at Avalyn PharmaALOFT-IPF Study &amp\; ALOFT-PPF StudyTrial S
 ponsor: Bristol Myers SquibbSpeaker: Moonmoon Kazi\, MD\, Senior Trial Phy
 sician at Bristol Myers SquibbREVERT-IPFTrial Sponsor: Tvardi Therapeutics
 Speaker: John Kauh\, MD\, Chief Medical Officer at Tvardi TherapeuticsDISC
 LAIMER: Participation in the CTI Webinar Series and references to specific
  commercial entities (companies) or products do not reflect endorsement by
  the PFF. The PFF does not endorse or promote any products or services par
 ticipants discuss in the CTI Webinar Series\, and participants cannot sugg
 est otherwise. Please note that any information contained in this presenta
 tion is for informational and educational purposes only. It is not intende
 d to be a substitute for professional medical advice. Always consult your 
 personal physician or health care provider to determine if a clinical tria
 l is right for you.
DTEND:20250219T190000Z
DTSTAMP:20260316T111553Z
DTSTART:20250219T180000Z
LOCATION:
SEQUENCE:0
SUMMARY:PFF Clinical Trial Innovation (CTI) Webinar Series February 2025
UID:RFCALITEM639092385531005296
X-ALT-DESC;FMTTYPE=text/html:Please join the PFF and industry representativ
 es for the PFF CTI Webinar Series. You will learn about various research s
 tudies underway to help find new treatments for pulmonary fibrosis and int
 erstitial lung disease.<br><br><div><strong>CTI Webinar Series February Pr
 esenters</strong></div><ul><li>MIST Study<ul><li>Trial Sponsor: Avalyn Pha
 rma</li><li><span style="background-color: initial\; font-family: inherit\
 ; font-size: inherit\; text-align: inherit\; text-transform: inherit\; wor
 d-spacing: normal\; caret-color: auto\; white-space: inherit">Speaker: Cra
 ig Conoscenti\, MD\, Senior Vice President of Clinical Development at Aval
 yn Pharma</span></li></ul></li><li>ALOFT-IPF Study &amp\; ALOFT-PPF Study<
 ul><li>Trial Sponsor: Bristol Myers Squibb</li><li>Speaker: Moonmoon Kazi\
 , MD\, Senior Trial Physician at Bristol Myers Squibb</li></ul></li><li>RE
 VERT-IPF<ul><li>Trial Sponsor: Tvardi Therapeutics</li><li>Speaker: John K
 auh\, MD\, Chief Medical Officer at Tvardi Therapeutics</li></ul></li></ul
 ><div><em style="background-color: initial\; font-family: inherit\; font-s
 ize: inherit\; text-align: inherit\; text-transform: inherit\; word-spacin
 g: normal\; caret-color: auto\; white-space: inherit">DISCLAIMER: Particip
 ation in the CTI Webinar Series and references to specific commercial enti
 ties (companies) or products do not reflect endorsement by the PFF. The PF
 F does not endorse or promote any products or services participants discus
 s in the CTI Webinar Series\, and participants cannot suggest otherwise. P
 lease note that any information contained in this presentation is for info
 rmational and educational purposes only. It is not intended to be a substi
 tute for professional medical advice. Always consult your personal physici
 an or health care provider to determine if a clinical trial is right for y
 ou.</em></div>
END:VEVENT
END:VCALENDAR
